Dr. Raymond Clarke from the Institute is keen to continue working on the following research work.
'PCA3 is the best biomarker for prostate cancer and we have recently
just redefined the PCA3 gene which has important implications for
improving detection of prostate cancer - the new gene elements are not expressed
in any other tissue of the body, not in normal prostate and not in benign
prostate hypoplasia -
only in prostate cancer and metastases - In collaboration with Dr Frank Gardiner
in Queensland (who pioneered the use of urines and prostatic fluid research for Prostate Cancer
detection) we hope to bring this research to the clinic to improve prostate
cancer detection, early intervention and treatment'.
Money raised will go to support this research - Worth a long ride we reckon!
You can donate at:
http://www.everydayhero.com.au/prostate
No comments:
Post a Comment